--- title: "广东广康生化科技股份有限公司 (300804.SZ)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/300804.SZ.md" symbol: "300804.SZ" name: "广东广康生化科技股份有限公司" industry: "化肥及农药" --- # 广东广康生化科技股份有限公司 (300804.SZ) | Item | Detail | |------|--------| | Industry | 化肥及农药 | | Location | 沪深市场 | | Website | [www.greatchem.com.cn](https://www.greatchem.com.cn) | ## Company Profile 公司自 2003 年成立以来,具有良好的产品开发能力、规模生产能力、质量控制能力和安全环保健康等管理能力,具备化合物分子结构设计、构效关系研究、合成路线设计、合成工艺优化等综合研发能力。公司的主要业务为从事农药原药、中间体、制剂的研发、生产和销售。公司的主要产品为灭菌丹、克菌丹、噻呋酰胺、土菌灵、萎锈灵、联苯肼酯、甲氧虫酰肼、甜菜宁、甜菜安、甜菜安、乙氧呋草黄。企业荣誉:中国农药发展与应用协会理事单位、中国石油化工优秀民营企业、中国农药工业协会 AA 级信用企业、广东省创新型企业、广东省知识产权贯标认证企业等。 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-21T04:30:10.000Z **Overall: B (0.37)** **Industry**: Fertilizers and Agricultural Chemicals | Metric | Value | |--------|-------| | Industry Ranking | 20 / 63 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 26.59% | | | Net Profit YoY | 36.03% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.47 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 3.35B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 788.99M | | **Multi Score**: B #### Profit Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 3.43% | C | | Profit Margin | 5.81% | B | | Gross Margin | 27.05% | C | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 26.59% | A | | Net Profit YoY | 36.03% | B | | Total Assets YoY | 14.90% | A | | Net Assets YoY | 3.77% | C | #### Cash Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 1721.24% | B | | OCF YoY | 26.59% | A | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.39 | C | #### Debt Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 37.80% | B | ```chart-data:radar { "title": "Longbridge Financial Score - 广东广康生化科技股份有限公司", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "C", "indicators": [ { "name": "ROE", "value": "3.43%", "rating": "C" }, { "name": "Profit Margin", "value": "5.81%", "rating": "B" }, { "name": "Gross Margin", "value": "27.05%", "rating": "C" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "26.59%", "rating": "A" }, { "name": "Net Profit YoY", "value": "36.03%", "rating": "B" }, { "name": "Total Assets YoY", "value": "14.90%", "rating": "A" }, { "name": "Net Assets YoY", "value": "3.77%", "rating": "C" } ] }, { "name": "Cash", "grade": "A", "indicators": [ { "name": "Cash Flow Margin", "value": "1721.24%", "rating": "B" }, { "name": "OCF YoY", "value": "26.59%", "rating": "A" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.39", "rating": "C" } ] }, { "name": "Security", "grade": "B", "indicators": [ { "name": "Gearing Ratio", "value": "37.80%", "rating": "B" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 藏格矿业 (SZ.000408) | A | C | D | A | D | B | | 02 | 亚钾国际 (SZ.000893) | A | A | D | B | B | B | | 03 | 扬农化工 (SH.600486) | B | B | B | B | B | B | | 04 | 川恒股份 (SZ.002895) | B | A | B | B | B | B | | 05 | 润丰股份 (SZ.301035) | B | B | B | D | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 73.18 | 36/63 | 91.52 | 62.04 | 55.28 | | PB | 2.47 | 37/63 | 2.38 | 2.08 | 1.46 | | PS (TTM) | 4.25 | 54/63 | 4.26 | 3.53 | 2.93 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2024-02-08T16:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 100% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 45.33 | ## References - [Company Overview](https://longbridge.com/en/quote/300804.SZ/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/300804.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/300804.SZ/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.